ARCHIVES

ESA Risk Mitigation Strategy Requires Training, Patient Consent, Documentation

This article is from The Cancer Letter archive.

Vol. 36 No. 06 | February 19, 2010

Download PDF Visit The Full Archive

Related Articles

How the Institute Fared In House Markup: Chart

July 18, 1997

In Brief: Weissman Heads DCBD Board; Extra Money For Grants Lifts Funding Level To 35%

October 14, 1977

NCI, NHGRI Fund Two More Components of TCGA Project.

October 27, 2006

Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer

February 25, 2011

EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure.

March 2, 2007

Research Contracts Branch Reorganized, Graalman On “Detail”

October 22, 1982